Public Health Service Food and Drug Administration Center for Drug Evaluation and
Research
Department
of Health and Human Services
Memorandum
DATE:
FROM: Marilyn R. Pitts, Pharm.D.
Postmarketing
Safety Evaluator
Office
of Drug Safety (ODS)
Division
of Drug Risk Evaluation, HFD-430
THROUGH: Mark Avigan, M.D., C.M., Director
Office of Drug Safety (ODS)
Division of Drug Risk Evaluation, HFD-430